XML 73 R4.htm IDEA: XBRL DOCUMENT v3.3.0.814
Unaudited Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2015
Dec. 31, 2014
Current Assets    
Cash and cash equivalents (variable interest entity restricted - 2015: $1; 2014: $1) $ 952 $ 780
Trade receivables - third party and affiliates (net of allowance for doubtful accounts - 2015: $6; 2014: $9) 793 801
Non-trade receivables, net 231 241
Inventories 738 782
Deferred income taxes 15 29
Marketable securities, at fair value 30 32
Other assets 37 33
Total current assets 2,796 2,698
Investments in affiliates 868 876
Property, plant and equipment (net of accumulated depreciation - 2015: $1,990; 2014: $1,816; variable interest entity restricted - 2015: $754; 2014: $535) 3,778 3,733
Deferred income taxes 278 253
Other assets (variable interest entity restricted - 2015: $40; 2014: $24) 350 377
Goodwill 716 749
Intangible assets (net of accumulated amortization - 2015: $536; 2014: $556) 122 132
Total assets 8,908 8,818
Current Liabilities    
Short-term borrowings and current installments of long-term debt - third party and affiliates 463 137
Trade payables - third party and affiliates 608 757
Other liabilities 331 432
Deferred income taxes 7 7
Income taxes payable 107 5
Total current liabilities 1,516 1,338
Long-term debt 2,541 2,608
Deferred income taxes 122 141
Uncertain tax positions 165 159
Benefit obligations 1,103 1,211
Other liabilities $ 264 $ 283
Commitments and Contingencies
Stockholders' Equity    
Preferred stock, $0.01 par value, 100,000,000 shares authorized (2015 and 2014: 0 issued and outstanding) $ 0 $ 0
Treasury stock, at cost (2015: 19,916,490 shares; 2014: 13,266,625 shares) (1,031) (611)
Additional paid-in capital 127 103
Retained earnings 3,962 3,491
Accumulated other comprehensive income (loss), net (292) (165)
Total Celanese Corporation stockholders' equity 2,766 2,818
Noncontrolling interests 431 260
Total equity 3,197 3,078
Total liabilities and equity 8,908 8,818
Series A common stock, $0.0001 par value, 400,000,000 shares authorized (2015: 166,620,081 issued and 146,703,591 outstanding; 2014: 166,169,335 issued and 152,902,710 outstanding)    
Stockholders' Equity    
Common stock 0 0
Series B common stock, $0.0001 par value, 100,000,000 shares authorized (2015 and 2014: 0 issued and outstanding)    
Stockholders' Equity    
Common stock $ 0 $ 0